Robert Shawah
Fundador en ACURX PHARMACEUTICALS, INC. .
Fortuna: 474 892 $ al 31/05/2024
Cargos activos de Robert Shawah
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ACURX PHARMACEUTICALS, INC. | Fundador | 01/07/2017 | - |
| Director Financiero/CFO | 01/07/2017 | - | |
| Comptroller/Controller/Auditor | 01/07/2017 | - |
Historial de carrera de Robert Shawah
Antiguos cargos conocidos de Robert Shawah.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Ameri100 Holdco, Inc.
 Ameri100 Holdco, Inc. MiscellaneousMiscellaneous Ameri100 Holdco, Inc. operates as an investment holding company. The company is headquartered in Delaware. | Director/Miembro de la Junta | 01/08/2018 | 01/12/2018 |
Dipexium Pharmaceuticals, Inc.
 Dipexium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dipexium Pharmaceuticals, Inc. is a late stage pharmaceutical company, which is focused on the development and commercialization of Locilex, a potent and broad spectrum topical antibiotic peptide for the treatment of mild and moderate skin and skin structure infections. The company was founded by Robert J. DeLuccia and David P. Luci on January 14, 2010 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 01/03/2014 | 01/04/2017 |
| Treasurer | 01/03/2014 | 01/04/2017 | |
| Baldwin Pearson & Co., Inc. | Corporate Officer/Principal | 01/01/2005 | 01/01/2013 |
Formación de Robert Shawah.
| Bucknell University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| Comptroller/Controller/Auditor | 2 |
| Treasurer | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
| Miscellaneous | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ACURX PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Dipexium Pharmaceuticals, Inc.
Dipexium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dipexium Pharmaceuticals, Inc. is a late stage pharmaceutical company, which is focused on the development and commercialization of Locilex, a potent and broad spectrum topical antibiotic peptide for the treatment of mild and moderate skin and skin structure infections. The company was founded by Robert J. DeLuccia and David P. Luci on January 14, 2010 and is headquartered in New York, NY. | Health Technology |
| Baldwin Pearson & Co., Inc. | |
Ameri100 Holdco, Inc.
Ameri100 Holdco, Inc. MiscellaneousMiscellaneous Ameri100 Holdco, Inc. operates as an investment holding company. The company is headquartered in Delaware. | Miscellaneous |
- Bolsa de valores
- Insiders
- Robert Shawah
- Experiencia
